BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,037 filers reported holding BAXTER INTL INC in Q1 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $603,236 | -17.0% | 15,984 | +0.2% | 0.02% | -10.5% |
| Q2 2023 | $726,955 | +13.0% | 15,956 | +0.6% | 0.02% | +11.8% |
| Q1 2023 | $643,403 | -20.1% | 15,863 | +0.4% | 0.02% | -19.0% |
| Q4 2022 | $805,326 | -20.1% | 15,800 | -15.5% | 0.02% | -19.2% |
| Q3 2022 | $1,008,000 | -29.6% | 18,706 | -16.0% | 0.03% | -21.2% |
| Q2 2022 | $1,431,000 | -16.7% | 22,281 | +0.6% | 0.03% | -15.4% |
| Q1 2022 | $1,718,000 | -19.3% | 22,158 | -10.6% | 0.04% | -7.1% |
| Q4 2021 | $2,128,000 | +5.6% | 24,795 | -1.1% | 0.04% | +2.4% |
| Q3 2021 | $2,016,000 | +9.7% | 25,067 | +9.8% | 0.04% | +28.1% |
| Q2 2021 | $1,838,000 | -4.8% | 22,835 | -0.3% | 0.03% | -5.9% |
| Q1 2021 | $1,931,000 | -14.1% | 22,898 | -18.3% | 0.03% | +13.3% |
| Q4 2020 | $2,249,000 | -6.6% | 28,033 | +0.3% | 0.03% | -9.1% |
| Q3 2020 | $2,407,000 | 0.0% | 27,953 | 0.0% | 0.03% | 0.0% |
| Q2 2020 | $2,407,000 | +11.3% | 27,953 | +5.0% | 0.03% | 0.0% |
| Q1 2020 | $2,162,000 | +30.4% | 26,631 | +34.3% | 0.03% | +10.0% |
| Q4 2019 | $1,658,000 | -2.5% | 19,833 | +2.0% | 0.03% | -18.9% |
| Q3 2019 | $1,701,000 | +15.4% | 19,442 | +8.0% | 0.04% | +5.7% |
| Q2 2019 | $1,474,000 | -75.0% | 17,997 | -75.2% | 0.04% | -67.3% |
| Q1 2019 | $5,889,000 | +19.8% | 72,431 | -3.0% | 0.11% | +30.5% |
| Q4 2018 | $4,914,000 | -26.7% | 74,660 | -14.1% | 0.08% | -19.6% |
| Q3 2018 | $6,703,000 | -3.8% | 86,949 | -7.8% | 0.10% | -1.9% |
| Q2 2018 | $6,966,000 | +18.4% | 94,339 | +4.3% | 0.10% | +6.1% |
| Q1 2018 | $5,883,000 | -19.6% | 90,452 | -20.1% | 0.10% | -19.0% |
| Q4 2017 | $7,319,000 | +3.8% | 113,226 | +0.7% | 0.12% | +4.3% |
| Q3 2017 | $7,052,000 | +4.1% | 112,387 | +0.4% | 0.12% | +1.8% |
| Q2 2017 | $6,776,000 | +33.0% | 111,928 | +13.9% | 0.11% | +26.7% |
| Q1 2017 | $5,096,000 | +104.5% | 98,256 | +74.8% | 0.09% | +83.7% |
| Q4 2016 | $2,492,000 | +8.1% | 56,212 | +16.1% | 0.05% | 0.0% |
| Q3 2016 | $2,305,000 | +141.9% | 48,427 | +129.8% | 0.05% | +145.0% |
| Q2 2016 | $953,000 | +10.9% | 21,069 | +0.7% | 0.02% | +5.3% |
| Q1 2016 | $859,000 | +8.3% | 20,918 | +0.7% | 0.02% | +11.8% |
| Q4 2015 | $793,000 | +20.0% | 20,781 | +3.2% | 0.02% | +21.4% |
| Q3 2015 | $661,000 | -52.9% | 20,136 | +0.3% | 0.01% | -50.0% |
| Q2 2015 | $1,403,000 | +3.6% | 20,067 | +1.5% | 0.03% | 0.0% |
| Q1 2015 | $1,354,000 | – | 19,772 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |